SG Americas Securities LLC Makes New $859,000 Investment in ICU Medical, Inc. (NASDAQ:ICUI)

SG Americas Securities LLC acquired a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,187 shares of the medical instruments supplier's stock, valued at approximately $859,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Arizona State Retirement System lifted its holdings in ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock valued at $1,044,000 after purchasing an additional 65 shares in the last quarter. Huntington National Bank raised its position in shares of ICU Medical by 6.2% in the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after buying an additional 82 shares during the last quarter. LPL Financial LLC raised its position in shares of ICU Medical by 2.0% in the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock valued at $747,000 after buying an additional 93 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock valued at $4,051,000 after buying an additional 136 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of ICU Medical by 27.2% in the first quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock valued at $99,000 after buying an additional 153 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at ICU Medical

In other ICU Medical news, Director David C. Greenberg sold 1,942 shares of the business's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $143.66, for a total transaction of $278,987.72. Following the sale, the director now directly owns 6,760 shares in the company, valued at approximately $971,141.60. The trade was a 22.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Elisha W. Finney sold 600 shares of the business's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $138.92, for a total transaction of $83,352.00. Following the completion of the sale, the director now owns 3,252 shares in the company, valued at $451,767.84. This represents a 15.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,097 shares of company stock worth $4,860,156. 1.50% of the stock is currently owned by insiders.

ICU Medical Stock Up 0.3%

ICU Medical stock traded up $0.33 during trading on Monday, reaching $128.07. The stock had a trading volume of 134,916 shares, compared to its average volume of 271,888. ICU Medical, Inc. has a 52-week low of $111.97 and a 52-week high of $196.26. The business has a 50 day moving average price of $134.70 and a 200 day moving average price of $147.30. The company has a quick ratio of 1.52, a current ratio of 2.59 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.15 billion, a PE ratio of -33.44 and a beta of 0.88.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.49. The business had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The company's revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.96 EPS. On average, analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analysts Set New Price Targets

ICUI has been the subject of a number of recent research reports. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Wall Street Zen upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. Raymond James Financial dropped their price target on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research report on Friday, May 9th. Finally, KeyCorp lowered their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Buy" and an average target price of $192.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.